Perivascular fat, AMP‐activated protein kinase and vascular diseases
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Perivascular adipose tissue (PVAT) is an active endocrine and paracrine organ that modulates vascular function, with implications for the pathophysiology of cardiovascular disease (CVD). Adipocytes and stromal cells contained within PVAT produce mediators (adipokines, cytokines, reactive oxygen species and gaseous compounds) with a range of paracrine effects modulating vascular smooth muscle cell contraction, proliferation and migration. However, the modulatory effect of PVAT on the vascular system in diseases, such as obesity, hypertension and atherosclerosis, remains poorly characterized. AMP‐activated protein kinase (AMPK) regulates adipocyte metabolism, adipose biology and vascular function, and hence may be a potential therapeutic target for metabolic disorders such as type 2 diabetes mellitus (T2DM) and the vascular complications associated with obesity and T2DM. The role of AMPK in PVAT or the actions of PVAT have yet to be established, however. Activation of AMPK by pharmacological agents, such as metformin and thiazolidinediones, may modulate the activity of PVAT surrounding blood vessels and thereby contribute to their beneficial effect in cardiometabolic diseases. This review will provide a current perspective on how PVAT may influence vascular function via AMPK. We will also attempt to demonstrate how modulating AMPK activity using pharmacological agents could be exploited therapeutically to treat cardiometabolic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799 · cited 1×
“Thus, the tissue-specific subunit composition may be important to determine a specialized cellular and systemic response to different metabolic stimuli (Kahn et al., 2005).”
BackgroundAdipose tissue, adipokines, and inflammation
Fantuzzi, G. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.02.023 · Cited by 2,606 · cited 1×
“Furthermore, in obese animals, administration of adiponectin has been found to improve insulin sensitivity and to decrease hyperglycaemia and the level of fatty acids in the plasma (Berg et al., 2002; Fantuzzi, 2005).”
BackgroundLeptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053 · cited 7×
“, 2005) and humans (Minokoshi et al., 2002) in comparison with lean controls.”
BackgroundResultInfluentialThe Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950 · cited 1×
“In human type 2 diabetic skeletal muscle, AMPK expression and activity are also unchanged in patients with a similar body mass (Shaw et al., 2005).”
BackgroundKern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883 · cited 1×
“AICAR has also been reported to stimulate release of adiponectin and inhibit release of cytokines such as TNF-α and IL-6, which have been implicated in the development of obesity-induced insulin resistance (Kern et al., 2001; Lihn et al., 2004).”
BackgroundUnexpected evidence for active brown adipose tissue in adult humans
Nedergaard, J., Bengtsson, T., & Cannon, B. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00691.2006 · Cited by 1,824 · cited 1×
“Fat cells in BAT are larger in size with multiple small lipid droplets and larger numbers of mitochondria (Cinti, 2005; Nedergaard et al., 2007).”
BackgroundHawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.009 · Cited by 1,589 · cited 1×
“The combination of allosteric modulation and phosphorylation leads to a >1000-fold increase in kinase activity (Hawley et al., 2005; Xie et al., 2006).”
BackgroundStatin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease
Nissen, S. E., Tuzcu, E. M., Schoenhagen, P., Crowe, T., Sasiela, W. J., Tsai, J., Orazem, J., Magorien, R. D., O'Shaughnessy, C., & Ganz, P. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042000 · Cited by 1,325
Interleukin-6-deficient mice develop mature-onset obesity
Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213 · cited 2×
“However, IL-6 knockout in mice can be linked with the development of mature-onset obesity (Wallenius et al., 2002) and diet-induced atherosclerosis (Madan et al., 2008), an effect that can be attributed to the reduced AMPK activity in IL-6-deficient mice (Kelly et al., 2004).”
Background
Cited by
Yuan, T., Yang, T., Chen, H., Fu, D., Hu, Y., Wang, J., Yuan, Q., Yu, H., Xu, W., & Xie, X. (2019) · Redox Biology · doi:10.1016/j.redox.2018.09.025 · Cited by 743
Perivascular adipose tissue inflammation in vascular disease
Nosalski, R., & Guzik, T. J. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13705 · Cited by 398
Endothelial dysfunction in obesity
Engin, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_15 · Cited by 255
The role of perivascular adipose tissue in obesity‐induced vascular dysfunction
Xia, N., & Li, H. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13650 · Cited by 206
“NO and H2S), prostacyclin, Ang 1–7, Ang II, methyl palmitate, ET-1 and ROS (e.g. superoxide, H2O2) (Gollasch, 2012; Szasz and Webb, 2012; Almabrouk et al., 2014; Tano et al., 2014).”
Zhang, Y., Shen, X., Xiao, X., Liu, M., Li, S., Yan, J., Jin, J., Gao, J., Zhen, C., Hu, N., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13578 · Cited by 55
Metadata
- Authors
- Almabrouk, T. A. M., Ewart, M. A., Salt, I. P., & Kennedy, S.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2014-01-13
- Volume
- 171
- Issue
- 3
- Pages
- 595-617
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1511269911
- Cited by
- 80
- References
- 43
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Perivascular fat, AMP‐activated protein kinase and vascular diseases. https://app.cochat.ai/papers/10.1111/bph.12479
- The paper
- Almabrouk, T. A. M., Ewart, M. A., Salt, I. P., & Kennedy, S. (2014). Perivascular fat, AMP‐activated protein kinase and vascular diseases. British Journal of Pharmacology. https://doi.org/10.1111/bph.12479
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.